Recursion to Participate in Upcoming Investor Conferences
SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences:
- SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences:
Citi's 18th Annual BioPharma Conference – September 6-7, 2023
Citi's Global Technology Conference – September 6-8, 2023
Cantor Global Healthcare Conference – September 26-28, 2023